10-Q: ModivCare Reports Mixed Q2 Results Amidst Goodwill Impairment
Quarterly Report
ModivCare's Q2 2024 results show consistent revenue year-over-year but a significant net loss due to a goodwill impairment charge.
Summary
- ModivCare's service revenue remained relatively flat at $698.3 million for the three months ended June 30, 2024, compared to $699.1 million for the same period last year.
- The company reported a net loss of $128.9 million for the quarter, significantly impacted by a $105.3 million goodwill impairment charge in the RPM segment.
- For the six months ended June 30, 2024, service revenue was $1.38 billion, a slight increase from $1.36 billion in the same period of 2023.
- The net loss for the first six months of 2024 was $151.2 million, compared to a net loss of $194.9 million in the first six months of 2023.
- The company's operating loss for the quarter was $98.9 million, compared to $175.8 million in the same quarter of the previous year.
- The operating loss for the first six months of 2024 was $102.3 million, compared to $167.7 million in the first six months of 2023.
- The company's cash and cash equivalents were $10.5 million as of June 30, 2024, compared to $2.2 million at the end of 2023.
- Short-term borrowings under the Revolving Credit Facility were $183 million as of June 30, 2024, up from $113.8 million at the end of 2023.
Sentiment
Score: 4
Explanation: The document presents mixed results with a significant net loss due to a goodwill impairment, offset by consistent revenue and improved cash position. The outlook is cautious due to debt levels and reliance on meeting operating projections.
Positives
- The company's service revenue remained consistent year-over-year.
- The net loss for the first six months of 2024 improved compared to the same period in 2023.
- The company successfully established a new $525 million Term Loan Facility and redeemed its 2025 Senior Unsecured Notes.
- Cash and cash equivalents increased to $10.5 million as of June 30, 2024, from $2.2 million at the end of 2023.
Negatives
- A significant goodwill impairment of $105.3 million was recorded in the RPM segment.
- The company reported a net loss of $128.9 million for Q2 2024.
- Short-term borrowings increased to $183 million as of June 30, 2024.
- The company's total assets decreased from $1.77 billion at the end of 2023 to $1.68 billion as of June 30, 2024.
Risks
- The company's ability to meet its financial covenants under its debt instruments is dependent on meeting operating projections.
- Failure to satisfy debt covenants could cause amounts to become due and payable prior to maturity.
- The company's liquidity is dependent on timely collection of contract receivables, which were approximately $159.3 million at June 30, 2024.
- Ongoing constraints in the labor market, particularly for healthcare professionals, could adversely impact the company's financial results.
- The company's stock price continues to be volatile, which could lead to further goodwill impairments.
- The company is subject to various regulatory reviews and governmental investigations, which could have a material adverse impact.
Future Outlook
The company expects its cash and cash equivalents, along with cash flows from operations and amounts available under the Revolving Credit Facility, to be sufficient to fund its operating expenses and expenditure requirements for the next twelve months. However, this is highly dependent on meeting operating projections and managing working capital.
Management Comments
- Management's assessment of its liquidity is highly dependent on its ability to meet its operating projections, including cash generated by operations.
- Management believes that the remediation measures described above will address the material weaknesses and strengthen the Company's overall internal control over financial reporting.
Industry Context
The company operates in the healthcare services industry, which is experiencing trends such as an aging population, increasing prevalence of chronic illnesses, and a shift towards value-based care. The company's performance is also affected by regulatory changes and macroeconomic conditions, including rising interest rates and labor shortages.
Comparison to Industry Standards
- ModivCare's performance is mixed when compared to industry standards. While revenue remained consistent, the significant goodwill impairment and net loss are concerning.
- Comparable companies in the healthcare services sector, such as those providing non-emergency medical transportation and personal care services, are also facing challenges related to labor costs and regulatory pressures.
- The company's debt levels and leverage ratio are higher than some of its peers, which could pose a risk in a rising interest rate environment.
- The company's focus on technology-enabled solutions and value-based care aligns with industry trends, but its ability to execute these strategies effectively remains to be seen.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Executive Officer | NA | L. Heath Sampson | NA | NA |
| Chief Financial Officer | NA | Barbara Gutierrez | NA | NA |
| Vice President | NA | Anne Bailey | NA | Amendment to Offer Letter |
| NA | Ilias Simpson | NA | 2024-05-02 | Separation Agreement |
| NA | Anne Bailey | NA | 2024-06-21 | Separation Agreement |
Legal Proceedings
- The company is involved in a class action lawsuit related to pay for live-in caregivers, but does not believe the outcome will have a material adverse effect.
- The company received an audit inquiry letter from HHS related to one of the business units that received PRF payments, but believes the payments received are substantiated.
Stakeholder Impact
- Shareholders may be concerned about the net loss and goodwill impairment.
- Employees may be affected by ongoing cost optimization and digitization efforts.
- Customers may experience changes in service delivery due to the company's focus on technology-enabled solutions.
- Creditors may be concerned about the company's debt levels and ability to meet financial covenants.
Next Steps
- The company will continue to focus on projects that automate, standardize, and centralize the company's control environment.
- Management will continue to monitor the progress of remediation efforts related to material weaknesses in internal control over financial reporting.
- The company will continue to monitor the performance of the business and the value of its stock price to determine if any impairments to goodwill could exist at any particular time.
Key Dates
| Date | Description |
|---|---|
| 2020-11-04 | Issued $500 million in 5.875% senior unsecured notes due 2025. |
| 2021-08-24 | Issued $500 million in 5.000% senior unsecured notes due 2029. |
| 2022-02-03 | Amended and restated credit agreement with JPMorgan Chase Bank, N.A. |
| 2023-05-11 | Department of Health and Human Services declared the end of the public health emergency for the COVID-19 pandemic. |
| 2023-06-26 | Entered into Amendment No. 1 to the Credit Agreement. |
| 2024-02-22 | Entered into Amendment No. 2 to the Credit Agreement. |
| 2024-06-30 | End of the quarterly period. |
| 2024-07-01 | Redeemed 2025 Senior Unsecured Notes and established a new Term Loan Facility. |
| 2024-08-02 | Shares outstanding as of this date were 14,240,177 (excluding treasury shares of 5,411,925). |
| 2024-08-07 | Date of the filing of the 10-Q report. |
Keywords
ModivCare, NEMT, Personal Care Services, Remote Patient Monitoring, Goodwill Impairment, Financial Results, Healthcare Services, Debt, Revolving Credit Facility, Term Loan Facility
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.